Increasing Access to Genomic Testing in Europe

The role of national genomic initiatives in increasing uptake of Advanced Diagnostics

What are the measures that leading EU Member States have taken to pave the way toward wider access to genomic testing? Last month, Richard Charter, our Vice President MedTech Market Access – Europe & Asia Pacific, joined the podcast by EUCOPE – European Confederation of Pharmaceutical Entrepreneurs to discuss what else can be done to ensure that genomic testing becomes accessible to the patients.

Listen to the episode “Increasing Access to Genomic Testing in Europe: The role of national genomic initiatives in increasing uptake of Advanced Diagnostics” below:

The episode “Increasing Access to Genomic Testing in Europe: The role of national genomic initiatives in increasing uptake of Advanced Diagnostics” is also available on the following platforms:

Google Podcasts    Pocket Casts    RadioPublic   Spotify

Meet the guests of this episode:
Multimedia
Published on:
June 21, 2022
Richard Charter

Richard Charter

Vice President MedTech Market Access - Europe & Asia Pacific, Alira Health Richard Charter has 15 years of experience in financial economics, health economics, consulting, market access, and pricing for MedTech companies. Alira Health is an international patient-centric and technology-enabled advisory firm whose mission is to humanize healthcare.
Caroline van der Meijden

Caroline van der Meijden

Director of Reimbursement EU, Agendia As an extension of her PhD in life sciences Caroline van der Meijden is an expert in Health Technology Assessment (HTA) with experience in both public and private sectors. Agendia is a global leader in innovative genomic technology and diagnostic tests for breast cancer.
Don Husereau

Don Husereau

Health Economist & Adjunct Professor at the University of Ottawa Don Husereau does freelance health care research, and works with private and public sector life sciences organizations to help them understand the value of health technology and its implications for health and innovation policy.
Matias Olsen

Matias Olsen

Public Affairs and Policy Manager at EUCOPE Matias Olsen supports EUCOPE on key topics, covering among others, EU HTA, advanced diagnostics, the Pharmaceutical Strategy, EU’s cancer plan, blood, tissues and cells legislation and relevant market access topics. He coordinates members’ thematic working groups, including the P&R/Market Access Working Group, the Genomics Working Group and the EU HTA Regulation Task Force.

Would you like to learn more about Advanced Diagnostics? Check out the episode of our podcast Transformation Talks “An Advanced Perspective on Advanced Diagnostics”!

Related news

Multimedia May 26, 2023
Webinar on Advancing Patient Engagement in the Medical Device / MedTech Industry
Engaging with patients, including their caregivers and advocates, is crucial during the planning and execution of clinical trials.
Medical Devices MedTech Patient Engagement
Blog May 17, 2023
Introduction to Patient Engagement in MedTech in the U.S.
Check out these key takeaways from our Playbook for Patient Engagement in MedTech in the U.S. and access the playbook download.
MedTech Patient Engagement USA
Events April 26, 2023
MedTech Forum 2023
We are excited to share that we will be sponsoring and speaking at MedTech Forum 2023. The MedTech Forum is the largest health and medical technology industry conference in Europe and(...)
MedTech Real-World Evidence (RWE)
Publications April 25, 2023
Comprehensive Guide to the Content of Integrated Summaries of Efficacy and Safety (ISE/ISS)
Read this to discover the content of Integrated Summaries of Efficacy and Safety (ISE/ISS).
MedTech
Events April 18, 2023
MedTech Impact Gala 2023
We are excited to share that we will sponsor and speak at MedTech Impact Symposium 2023.  The Symposium is organized by Massachusetts Medical Device Industry Council (MassMEDIC) and(...)
Medical Devices MedTech
Events April 18, 2023
MedTech Impact Symposium 2023
We are excited to share that we will sponsor and speak at MedTech Impact Symposium 2023.  The Symposium is organized by Massachusetts Medical Device Industry Council (MassMEDIC) and(...)
Medical Devices MedTech
Blog April 17, 2023
Reimbursement of Rare Disease Drugs in Italy: Challenges and Hopes for the Future
When it comes to rare diseases, Italy has done a good job in bringing EMA-approved drugs, including orphan drugs, to the Italian market. But  multiple challenges exist, many of which(...)
Italy Market Access Pharma Rare Disease Real-World Evidence (RWE)
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.